Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This is an 8-week double-blind, placebo-controlled, randomized, parallel-group study with an
additional two week baseline observation period to evaluate the safety of combination herbal
therapy (CHT) versus placebo and short and long-term efficacy in terms of improved IBS,
overall quality of life (QOL) and symptomatology.